PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494,884 | -26.9% | 80,600 | -25.4% | 0.00% | 0.0% |
| Q2 2023 | $676,706 | +125.2% | 108,100 | +71.6% | 0.00% | +100.0% |
| Q1 2023 | $300,534 | +75.9% | 63,005 | +220.8% | 0.00% | 0.0% |
| Q4 2022 | $170,868 | -31.4% | 19,640 | -6.1% | 0.00% | 0.0% |
| Q3 2022 | $249,000 | +22.1% | 20,923 | +46.1% | 0.00% | 0.0% |
| Q2 2022 | $204,000 | -71.1% | 14,325 | -57.7% | 0.00% | 0.0% |
| Q1 2022 | $706,000 | -9.8% | 33,900 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $783,000 | -22.5% | 33,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,010,000 | -12.8% | 33,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,158,000 | +91.4% | 33,900 | +84.2% | 0.00% | +100.0% |
| Q1 2021 | $605,000 | – | 18,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 2,336,909 | $48,654,000 | 28.27% |
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $67,351,000 | 25.73% |
| OUP Management Co., LLC | 989,232 | $20,596,000 | 15.68% |
| Nextech Invest Ltd. | 1,385,807 | $28,853,000 | 8.24% |
| Boxer Capital, LLC | 3,498,636 | $72,842,000 | 3.74% |
| COWEN AND COMPANY, LLC | 1,261,529 | $26,265,000 | 2.53% |
| Orbimed Advisors | 6,855,423 | $142,730,000 | 2.31% |
| RTW INVESTMENTS, LP | 3,872,154 | $80,618,000 | 1.67% |
| PERSONAL CFO SOLUTIONS, LLC | 350,342 | $7,294,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 135,500 | $2,821,000 | 1.32% |